These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9343272)

  • 1. Growth hormone therapy in pre-pubertal children with Noonan syndrome: first year growth response and comparison with Turner syndrome.
    De Schepper J; Otten BJ; François I; Bourguignon JP; Craen M; Van der Burgt I; Massa GG
    Acta Paediatr; 1997 Sep; 86(9):943-6. PubMed ID: 9343272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short stature and its treatment in Turner and Noonan syndromes.
    Chacko EM; Rapaport R
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):40-6. PubMed ID: 22157403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved final height with long-term growth hormone treatment in Noonan syndrome.
    Osio D; Dahlgren J; Wikland KA; Westphal O
    Acta Paediatr; 2005 Sep; 94(9):1232-7. PubMed ID: 16203673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
    Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short stature in Noonan syndrome: response to growth hormone therapy.
    Kirk JM; Betts PR; Butler GE; Donaldson MD; Dunger DB; Johnston DI; Kelnar CJ; Price DA; Wilton P; Group tU
    Arch Dis Child; 2001 May; 84(5):440-3. PubMed ID: 11316696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
    Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
    Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT; Eklöf O; Ivarsson S; Aronson S; Westphal O; Sipilä I; Kaitila I; Bland J; Veimo D; Müller J; Mohnike K; Neumeyer L; Ritzen M; Hagenäs L
    Acta Paediatr; 2005 Oct; 94(10):1402-10. PubMed ID: 16299871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Dutch Growth Hormone Working Group.
    Nienhuis HE; Rongen-Westerlaken C; Wit JM; Otten BJ; de Muinck Keizer-Schrama SM; Drayer NM; Delemarre-van de Waal HA; Vulsma T; Oostdijk W; Waelkens JJ
    Horm Res; 1993; 39 Suppl 2():31-6. PubMed ID: 8359786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment in Noonan syndrome.
    Tanaka T
    Acta Paediatr Jpn; 1996 Feb; 38(1):99-101. PubMed ID: 8992871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decade of growth hormone treatment in girls with Turner syndrome in the UK. UK KIGS Executive Group.
    Betts PR; Butler GE; Donaldson MD; Dunger DB; Johnston DI; Kelnar CJ; Kirk J; Price DA; Wilton P
    Arch Dis Child; 1999 Mar; 80(3):221-5. PubMed ID: 10325700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
    Li J; Wu W; Liang Y; Luo XP
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
    [No Abstract]   [Full Text] [Related]  

  • 17. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Price DA; Albertsson-Wikland K
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():69-74. PubMed ID: 8219480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.